rs373898335

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The ENST00000609883.3(RTL5):​c.1001A>G​(p.Asn334Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000653 in 1,208,951 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.000050 ( 0 hom. 14 hem. )

Consequence

RTL5
ENST00000609883.3 missense

Scores

13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.507

Publications

0 publications found
Variant links:
Genes affected
RTL5 (HGNC:29430): (retrotransposon Gag like 5)
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015117884).
BS2
High Hemizygotes in GnomAd4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.281-1539T>C intron_variant Intron 1 of 7 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTL5ENST00000609883.3 linkc.1001A>G p.Asn334Ser missense_variant Exon 1 of 1 6 ENSP00000476792.1 Q5HYW3
NHSL2ENST00000633930.2 linkc.281-1539T>C intron_variant Intron 1 of 7 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1

Frequencies

GnomAD3 genomes
AF:
0.000216
AC:
24
AN:
111132
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000722
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000192
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000826
AC:
15
AN:
181596
AF XY:
0.000104
show subpopulations
Gnomad AFR exome
AF:
0.000807
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000492
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000501
AC:
55
AN:
1097819
Hom.:
0
Cov.:
33
AF XY:
0.0000385
AC XY:
14
AN XY:
363249
show subpopulations
African (AFR)
AF:
0.000530
AC:
14
AN:
26398
American (AMR)
AF:
0.0000568
AC:
2
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19383
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54140
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40521
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.0000380
AC:
32
AN:
841758
Other (OTH)
AF:
0.000152
AC:
7
AN:
46077
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000216
AC:
24
AN:
111132
Hom.:
0
Cov.:
22
AF XY:
0.000150
AC XY:
5
AN XY:
33324
show subpopulations
African (AFR)
AF:
0.000722
AC:
22
AN:
30486
American (AMR)
AF:
0.000192
AC:
2
AN:
10422
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3559
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5934
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53064
Other (OTH)
AF:
0.00
AC:
0
AN:
1497
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000238
ESP6500AA
AF:
0.000900
AC:
3
ESP6500EA
AF:
0.000154
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.00
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 08, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1001A>G (p.N334S) alteration is located in exon 1 (coding exon 1) of the RGAG4 gene. This alteration results from a A to G substitution at nucleotide position 1001, causing the asparagine (N) at amino acid position 334 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.97
CADD
Benign
11
DANN
Benign
0.73
DEOGEN2
Benign
0.0038
T
FATHMM_MKL
Benign
0.043
N
LIST_S2
Benign
0.34
T
M_CAP
Benign
0.0050
T
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.51
PrimateAI
Benign
0.30
T
Sift4G
Benign
0.13
T
Polyphen
0.0050
B
Vest4
0.13
MVP
0.014
ClinPred
0.0084
T
GERP RS
0.23
Varity_R
0.039
gMVP
0.30
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373898335; hg19: chrX-71350390; API